Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Bioavailability Enhancement: Drug Permeability Enhancement01:27

Bioavailability Enhancement: Drug Permeability Enhancement

176
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
176
Drug Delivery: Overview01:16

Drug Delivery: Overview

703
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
703
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention01:05

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

184
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
184

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Bidirectional Regulation of NLRP3 Inflammasome and Mitochondrial Quality Control in Sepsis: Mechanisms and Therapeutic Implications.

Mediators of inflammation·2026
Same author

Elevated Prevalence of Oral HPV Infection Among Females with Periodontitis: A Cross-Sectional Study.

Oral health & preventive dentistry·2026
Same author

Enhanced safety and potency in local angiogenic growth factor delivery via aptamer functionalization of hydrogels.

Journal of controlled release : official journal of the Controlled Release Society·2025
Same author

Current Modalities in Soft-Tissue Reconstruction and Vascularized Adipose Engineering.

Biomolecules·2025
Same author

Association of the blood urea nitrogen to serum albumin ratio and 28-day all-cause mortality in patients with cardiac arrest: a retrospective cohort study using the MIMIC-IV database.

Frontiers in cardiovascular medicine·2025
Same author

DNA-triggered activation of aptamer-neutralized enzyme for <i>in situ</i> formation of injectable hydrogel.

Nanoscale horizons·2025

相关实验视频

Updated: Jan 10, 2026

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

4.3K

药物交付开发中的aptamers.

Connie Wen1, Yixun Wang1, Yong Wang1

  • 1Department of Biomedical Engineering, The Pennsylvania State University, University Park, PA 16802, USA.

Materials today (Kidlington, England)
|November 27, 2025
PubMed
概括

体或"化学抗体"是具有高亲和度结合的多功能核酸. 本综述探讨了它们在药物输送系统中的各种治疗用途和挑战.

科学领域:

  • 生物化学 生化学
  • 分子生物学分子生物学
  • 药物输送系统 药物输送系统

背景情况:

  • 体是短,单链核酸,模仿抗体.
  • 它们对目标分子具有很高的亲和力和特异性.
  • 这使得它们在各种生物医学应用中成为有希望的工具.

研究的目的:

  • 审查阿普他默的各种治疗应用.
  • 讨论在独立药物治疗中使用阿普坦.
  • 探索体作为各种治疗药物的载体,并使药物输送系统功能化.

主要方法:

  • 在治疗和药物输送中对阿帕特默应用的文献综述.
  • 基于aptamer的药物输送系统的分析,包括纳米粒子和生物材料.
  • 讨论挑战和未来的方向.

主要成果:

  • 阿普塔默可以作为独立药物.
  • 它们作为小分子,核酸,,蛋白质和抗体的有效载体.
  • 适合剂可以功能化纳米粒子和散装生物材料,以提供有针对性的交付.

结论:

关键词:
亚普特美尔 (Aptamer) 是一种药物.药物运输 药物运输 药物运输水凝是一种水凝.纳米颗粒 纳米颗粒

更多相关视频

Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins
11:34

Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins

Published on: August 9, 2019

7.1K
Kinetic Screening of Nuclease Activity using Nucleic Acid Probes
06:52

Kinetic Screening of Nuclease Activity using Nucleic Acid Probes

Published on: November 1, 2019

8.6K

相关实验视频

Last Updated: Jan 10, 2026

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

4.3K
Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins
11:34

Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins

Published on: August 9, 2019

7.1K
Kinetic Screening of Nuclease Activity using Nucleic Acid Probes
06:52

Kinetic Screening of Nuclease Activity using Nucleic Acid Probes

Published on: November 1, 2019

8.6K
  • 由于其特定的结合性质,aptamers提供了多功能治疗潜力.
  • 它们在药物输送系统中的应用,包括纳米粒子,正在扩大.
  • 解决挑战对于成功的临床转化基于aptamer的疗法至关重要.